C0142812||Sodium Butyrate
C0038969||Ultrabraid
C0142812||NaBu
C0038969||suture
C0302600||Angiogenesis
C1820201||Tissue Remodelling
C0039508||Tendon
C0561852||bones Injury
C0142812||Sodium butyrate
C0142812||NaBu
C0015691||short-chain fatty acid
C0015691||short-chain fatty acid
C0596087||anti-angiogenic agent
C0027651||tumour
C0302600||angiogenesis
C0684309||models
C0142812||NaBu
C0043240||healing
C0039508||tendon
C0561852||bone injury
C1820201||tissue remodelling
C0142812||NaBu
C1515653||in vitro
C1515655||in vivo
C0005507||assays
C0302600||angiogenesis
C0142812||NaBu
C0038969||UltraBraid
C0142812||NaBu
C0038969||suture
C0302600||pro-angiogenic
C1622501||migration
C2752214||tube formation
C2699153||cell invasion
C3667982||bovine
C0003483||aortic
C0225336||endothelial cells
C0225336||bovine aortic endothelial cells
C0007634||cell
C0142812||NaBu
C1171362||expression of proteins
C0302600||angiogenic
C0037083||cell signalling
C0257292||p-PKCβ1
C0059239||p-FAK
C0082529||p-ERK1
C0170168||2
C0079904||p-NFκβ
C0753837||p-PLCγ1
C0378796||p-VEGFR2
C0243077||inhibitors
C0378796||VEGFR2
C0257292||PKCβ1
C0302600||angiogenic
C1515655||in vivo
C0005507||assays
C0142812||NaBu
C0027686||neovascularization
C0021102||sponge implants
C0026809||mice
C0005847||vessels
C0019046||haemoglobin
C0021102||implants
C0142812||NaBu
C0302600||angiogenesis
C1515974||site
C3714653||vasculature
C0043240||healing